8-K/A: Healthcare Triangle Amends 8-K with Acquired Company Financials
Acquisition Financial Disclosure Amendment
Healthcare Triangle, Inc. filed an amendment to its Form 8-K, providing the necessary financial statements for its recently acquired subsidiaries, Teyam 360 S.L. and Datono Mediacin S.L.
Summary
- This filing is an amendment (Form 8-K/A) to a previously filed Current Report on Form 8-K.
- The amendment's purpose is to include the required financial statements for Teyam 360 S.L. and Datono Mediacin S.L., which were acquired by Healthcare Triangle's wholly owned subsidiary, Teyame AI Holdings Inc.
- The acquisition was completed pursuant to a Share Purchase Agreement dated January 22, 2026.
- The amendment includes audited financial statements for Teyam 360 S.L. and Datono Mediacin S.L. for the fiscal years ended December 31, 2025, and 2024.
- It also includes unaudited pro forma condensed combined financial information for Healthcare Triangle, Inc., Teyame 360 S.L., and Datono Mediacin S.L.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral; it's a procedural amendment providing necessary financial data for a past acquisition rather than new strategic information or performance updates.
Positives
- The filing provides essential financial disclosures for the acquired entities, fulfilling regulatory requirements.
- The inclusion of audited financial statements for Teyam 360 S.L. and Datono Mediacin S.L. offers transparency into their financial performance for 2024 and 2025.
- The pro forma financial information gives an indication of the combined entity's financial position as of December 31, 2025.
Negatives
- The filing is an amendment, indicating that initial disclosures were incomplete.
- The pro forma financial information explicitly states it does not reflect potential cost savings, synergies, or integration costs, limiting its predictive value.
Risks
- The filing references forward-looking statements that are subject to known and unknown risks and uncertainties, as detailed in the Company's other SEC filings.
- The acquired companies' financial statements are subject to the inherent risks and uncertainties of operating in their respective markets.
Future Outlook
The filing itself does not provide a future outlook for Healthcare Triangle, Inc. It primarily serves to provide historical financial information for the acquired entities and pro forma combined data. Forward-looking statements are referenced as being contained in other company filings.
Industry Context
StockSavvy.ai notes that this filing is a procedural amendment to an acquisition announcement, providing necessary financial disclosures for the acquired entities. The trend of consolidation in the technology and healthcare sectors, particularly involving AI-driven solutions, continues, making such acquisitions common.
Comparison to Industry Standards
- The financial statements of Teyame 360 S.L. and Datono Mediacin S.L. are presented in accordance with US GAAP, which is the standard for publicly traded companies in the United States.
- The audit reports from KPSN & Associates LLP indicate that the financial statements present fairly, in all material respects, the financial position and results of operations of the acquired companies, aligning with standard audit practices.
- The pro forma combined financial information is presented in accordance with SEC regulations for such disclosures, allowing for a hypothetical view of the combined entity's financial state.
Related Party Transactions
- The financial statements of Teyame 360 S.L. include balances due from affiliates, such as 'Long-term credit with Datono' ($787,906 in 2025) and 'Teyame Portugal Current Account'.
- The financial statements of Datono Mediacin S.L. include balances due to affiliates, such as 'Long-term debt with Teyam 360' ($787,906 in 2025) and 'Mimonkey Mobile Current Account'.
Stakeholder Impact
- Shareholders gain greater transparency into the financial performance of the acquired entities, aiding in valuation assessments.
- Creditors of Healthcare Triangle, Inc. will have a clearer picture of the combined entity's financial leverage and obligations.
- Management can now proceed with integrating the acquired businesses with a more complete understanding of their financial standing.
Next Steps
- Investors and analysts will review the provided financial statements of Teyam 360 S.L. and Datono Mediacin S.L. to assess their financial health.
- The pro forma combined financial information will be analyzed to understand the potential financial impact of the acquisition on Healthcare Triangle, Inc.
Key Dates
| Date | Description |
|---|---|
| January 22, 2026 | Date of the Share Purchase Agreement for the acquisition. |
| December 31, 2024 | Fiscal year-end for which financial statements of acquired companies are provided. |
| December 31, 2025 | Fiscal year-end for which financial statements of acquired companies are provided, and balance sheet date for pro forma information. |
| March 31, 2026 | Date of the independent registered public accounting firm's report on the financial statements of Teyame 360 S.L. and Datono Mediacin S.L. |
| April 7, 2026 | Date of the Form 8-K/A filing. |
Keywords
SEC Filing, Form 8-K/A, Amendment, Acquisition, Financial Statements, Teyame 360 S.L., Datono Mediacin S.L., Healthcare Triangle, Inc.
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.